Acasti Pharma Inc Foglalás / Részvény
Mi az Acasti Pharma Inc Foglalás / Részvény?
A Foglalás / Részvény az Acasti Pharma Inc - 17.88
Mi a Foglalás / Részvény meghatározása?
Az egy részvényre jutó könyv szerinti érték egy vállalat eszköze, mínusz kötelezettségek, osztva a fennálló részvények számával.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Foglalás / Részvény a Health Care szektor a NASDAQ-on cégekben a Acasti Pharma Inc -hoz képest
Mit csinál Acasti Pharma Inc?
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
foglalás / részvény -hoz hasonló cégek Acasti Pharma Inc
- NYLI MacKay DefinedTerm Muni Opportunities Fund nak Foglalás / Részvény 17.84 van
- Orchard Therapeutics plc nak Foglalás / Részvény 17.85 van
- Charle Co nak Foglalás / Részvény 17.85 van
- Marcus & Millichap Inc nak Foglalás / Részvény 17.86 van
- International Business Machines nak Foglalás / Részvény 17.86 van
- Square Enix Co nak Foglalás / Részvény 17.88 van
- Acasti Pharma Inc nak Foglalás / Részvény 17.88 van
- Olin nak Foglalás / Részvény 17.88 van
- Orphazyme A/S nak Foglalás / Részvény 17.88 van
- Quanex Building Products Corp nak Foglalás / Részvény 17.89 van
- Canoe EIT Income Fund nak Foglalás / Részvény 17.89 van
- Libas Designs nak Foglalás / Részvény 17.89 van
- Incyte nak Foglalás / Részvény 17.89 van